Use access key #2 to skip to page content.

IBDvalueinvestin (98.58)

$700M potential drug just Approved by FDA



July 16, 2009 – Comments (0) | RELATED TICKERS: BDSI

The global market for pain medication generates annual sales of over $30 billion. Datamonitor estimates the current market for the proposed use of Onsolis™ to be approximately $700 million. BDSI® believes that Onsolis™ has the potential to capture a significant share of the U.S. market for this use, which is estimated to result in annual peak sales of over $200 million.

0 Comments – Post Your Own

Featured Broker Partners